48 results on '"Rueter, Jens"'
Search Results
2. Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer
3. Epistemic Beliefs: Relationship to Future Expectancies and Quality of Life in Cancer Patients
4. Differences in cancer patients’ and clinicians’ preferences for disclosure of uncertain genomic tumor testing results
5. Molecular profiling of gynecologic cancers for treatment and management of disease – demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants
6. Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
7. Sociodemographic differences in treatment and survival for patients who receive genomic tumor testing in a rural state.
8. Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study
9. Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI).
10. Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
11. Patientsʼ Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices
12. Feasibility and Value of Genomic-Profiling in Cancer of Unknown Primary: Real-World Evidence from Prospective Profiling Study
13. Die institutionelle Organisation der Armut. Historische Differenzlinien zwischen Fürsorge und Sozialtechnologie
14. Einleitung
15. Advancing Genomic Cancer Medicine in Rural and Underserved States.
16. Regulatory T Cells: A New Frontier in Cancer Immunotherapy
17. The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State.
18. CD26-/DPP IV-Positive Lymphocytes in Murine Acute Experimental Colitis
19. Inhibition of Dipeptidylpeptidase IV (DPP IV, CD26) Activity Modulates Surface Expression of CTLA-4 in Stress-Induced Abortions
20. Urban-Rural and Socioeconomic Differences in Patient Knowledge and Perceptions of Genomic Tumor Testing.
21. 307 Patients expectations of benefits from large-panel genomic tumor testing in rural community oncology practices
22. Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer
23. Molecular profiling of CNS tumors for the treatment and management of disease
24. Maine Cancer Genomics Initiative: A Model for Translational Outreach
25. Clinical Utility of Molecular Profiling in Recurrent Glioblastoma Multiforme
26. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence
27. BIOM-23. MOLECULAR PROFILING IDENTIFIES NOVEL BIOMARKERS IN A RURAL COHORT OF PATIENTS WITH GLIOBLASTOMA
28. The influence of uncertainty and uncertainty tolerance on attitudes and self-efficacy about genomic tumor testing
29. Prospective study for comprehensive genomic profiling (GP) in cancer of unknown primary (CUP): Feasibility, molecular landscape, and clinical utility in current era.
30. Prediction of Tissue of Origin and Molecular Subtypes for Cancer of Unknown Primary Using Machine Learning
31. Community oncologists' perceptions and utilization of large-panel genomic tumor testing.
32. The influence of uncertainty and uncertainty tolerance on attitudes and self-efficacy about genomic tumor testing.
33. A donor-dependent in vivo model for single agent and drug combination cytokine release syndrome safety evaluation.
34. Utilizing data from patient-derived xenograft mouse models of human tumors to inform clinical decision making in Molecular Tumor Boards (MTB) deliberations.
35. Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease
36. Additive and synergistic inhibition of mantle cell lymphoma cell growth by combining olaparib with ibrutinib
37. Abstract 2033: Testing the combined effects of low dose olaparib plus ibrutinib on MCL cytotoxicity
38. Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
39. TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study
40. TMOD-39. A NOVEL EX VIVO TUMOR SLICE CULTURE SYSTEM AS A TOOL FOR BASIC AND CLINICAL RESEARCH
41. Health care utilization and behavior changes after workplace genetic testing at a large US health care system
42. Abstract 649: Biobank collaboration enables cancer modeling with high quality biospecimens and data
43. A Novel Automated Analysis Of Flow Cytometry Data Identifies Distinct Cell Signatures In The Immune System Of CLL Patients
44. Widerstand an allen Fronten! Plädoyer für eine selbstbestimmtere, politische und kritische Soziale Arbeit
45. Mechanismen psychosozialer DeKonstruktion im globalen Kapitalismus
46. Die Anatomie der Gesellschaft
47. Socioeconomic and Urban-Rural Disparities in Genome-Matched Treatment Receipt and Survival after Genomic Tumor Testing.
48. Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.